KALA BIO Secures $125 Million in Private Placement Funding
KALA BIO Secures $12.5 Million in Private Placement FundingKALA BIO, Inc. (NASDAQ:KALA), a leading biopharmaceutical company focused on developing therapies for eye diseases, has announced a successful private placement...
Jun 27, 2024
• Major Pharmaceutical Preparations Industry
Financing Agreement